Skip to main content

Table 3 Changes in clinical measures at 12 months between participants randomised to usual practice (control) or to the 3R intervention

From: Effectiveness of the Ready to Reduce Risk (3R) complex intervention for the primary prevention of cardiovascular disease: a pragmatic randomised controlled trial

VariableNumber of participants (%)Mean (SD)Adjusted difference at follow-up*
ControlInterventionControlInterventionCoefficient (95% CI)P value
BMI (kg/m2)86 (80)69 (66)28.60 (5.15)28.29 (4.64)− 0.36 (− 0.77 to 0.05)0.088
Body weight (kg)86 (80)69 (66)80.41 (17.43)79.88 (16.34)− 0.99 (− 2.12 to 0.13)0.084
Waist circumference (cm)86 (80)69 (66)99.44 (13.96)98.22 (13.13)− 2.55 (− 4.55 to − 0.55)0.013
Hip circumference (cm)86 (80)69 (66)107.39 (10.63)107.70 (9.75)0.79 (− 1.14 to 2.73)0.419
Systolic BP (mmHg)86 (80)69 (66)141.93 (19.04)137.55 (18.96)− 4.19 (− 9.13 to 0.76)0.096
Diastolic BP (mmHg)86 (80)69 (66)85.00 (9.77)80.52 (10.88)− 4.28 (− 6.98 to − 1.58)0.002
Total cholesterol (mmol/l)86 (80)69 (66)5.46 (1.01)5.21 (0.70)− 0.21 (− 0.46 to 0.05)0.120
HDL cholesterol (mmol/l)86 (80)69 (66)1.65 (0.59)1.63 (0.45)0.01 (− 0.06 to 0.08)0.814
TC-to-HDL ratio86 (80)69 (66)3.59 (1.14)3.44 (1.04)− 0.18 (− 0.40 to 0.05)0.128
CVD risk score86 (80)69 (66)17.06 (10.30)16.71 (9.20)− 1.36 (− 3.28 to 0.56)0.165
Number of prescriptions99 (93)92 (88)10.80 (3.95)11.82 (3.62)0.98 (− 0.07 to 2.04)0.067
  1. CI confidence interval
  2. *Adjusted difference at 12 months between treatment groups with 95% confidence interval, P value; adjusted for baseline value and stratification categories (age and sex)